Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUNIC, INC. Director's Dealing 2020

Apr 30, 2020

10196_dirs_2020-04-30_3fb44978-789f-4207-b2bb-6a1f5c2e7910.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2020-04-29

Reporting Person: Whaley Glenn (PAO and PFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-29 Stock Option $8.84 A 15000 Acquired 2030-04-29 Common Stock (15000) Direct

Footnotes

F1: 3,750 of the shares underlying the option (the "Underlying Shares") vest on the one-year anniversary of the grant date. Thereafter, 330 of the Underlying Shares vest on the thirteen (13) month anniversary of the grant date, and 312 of the Underlying Shares vest on each successive one-month anniversary thereafter for the next thirty five (35) months.